EP0923564A4 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
EP0923564A4
EP0923564A4 EP97939664A EP97939664A EP0923564A4 EP 0923564 A4 EP0923564 A4 EP 0923564A4 EP 97939664 A EP97939664 A EP 97939664A EP 97939664 A EP97939664 A EP 97939664A EP 0923564 A4 EP0923564 A4 EP 0923564A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97939664A
Other languages
German (de)
French (fr)
Other versions
EP0923564A1 (en
Inventor
Cora S Grossman
Joseph M Gruber
Chuan Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hawaii
Wayne State University
Eli Lilly and Co
Original Assignee
University of Hawaii
Wayne State University
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hawaii, Wayne State University, Eli Lilly and Co filed Critical University of Hawaii
Publication of EP0923564A1 publication Critical patent/EP0923564A1/en
Publication of EP0923564A4 publication Critical patent/EP0923564A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
EP97939664A 1996-08-30 1997-08-28 Pharmaceutical compounds Withdrawn EP0923564A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2507896P 1996-08-30 1996-08-30
US25078P 1996-08-30
PCT/US1997/015236 WO1998008829A1 (en) 1996-08-30 1997-08-28 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
EP0923564A1 EP0923564A1 (en) 1999-06-23
EP0923564A4 true EP0923564A4 (en) 1999-12-08

Family

ID=21823932

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97939664A Withdrawn EP0923564A4 (en) 1996-08-30 1997-08-28 Pharmaceutical compounds

Country Status (5)

Country Link
EP (1) EP0923564A4 (en)
JP (1) JP2001500853A (en)
AU (1) AU4169897A (en)
CA (1) CA2264297A1 (en)
WO (1) WO1998008829A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0869786B1 (en) * 1995-12-22 2003-03-05 Eli Lilly And Company Pharmaceutical compounds
US5977387A (en) * 1996-08-30 1999-11-02 Eli Lilly And Company Process for preparing pharmaceutical compounds
US6020512A (en) * 1996-09-06 2000-02-01 Eli Lilly And Company Process and novel intermediates
EA199900770A1 (en) * 1997-02-26 2000-04-24 Эли Лилли Энд Компани METHOD OF OBTAINING PHARMACEUTICAL COMPOUNDS
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
DE19913995A1 (en) 1999-03-29 2000-10-05 Basf Ag Process for the preparation of granular N-alkylamonium acetonitrile salts
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9808829A1 *

Also Published As

Publication number Publication date
EP0923564A1 (en) 1999-06-23
WO1998008829A1 (en) 1998-03-05
AU4169897A (en) 1998-03-19
CA2264297A1 (en) 1998-03-05
JP2001500853A (en) 2001-01-23

Similar Documents

Publication Publication Date Title
GB9602080D0 (en) Pharmaceutical compounds
GB9502874D0 (en) Pharmaceutical compounds
GB9423542D0 (en) Pharmaceutical compounds
GB9700504D0 (en) Pharmaceutical compounds
GB9410387D0 (en) Pharmaceutical compounds
GB9502861D0 (en) Pharmaceutical compounds
GB2286394B (en) Pharmaceutical compounds
GB9426224D0 (en) Pharmaceutical compounds
GB9609976D0 (en) Pharmaceutical compounds
EP1003495A4 (en) Pharmaceutical compounds
GB9716244D0 (en) Pharmaceutical compounds
GB9418326D0 (en) Pharmaceutical compounds
GB9621789D0 (en) Pharmaceutical compounds
GB9417102D0 (en) Pharmaceutical compounds
EP0923564A4 (en) Pharmaceutical compounds
ZA979329B (en) Pharmaceutical compounds
GB9700895D0 (en) Pharmaceutical compounds
GB9426071D0 (en) Pharmaceutical compounds
GB9626151D0 (en) Pharmaceutical compounds
GB9426080D0 (en) Pharmaceutical compounds
GB9402805D0 (en) Pharmaceutical compounds
ZA971668B (en) Pharmaceutical compounds
GB9621365D0 (en) Pharmaceutical compounds
GB9613997D0 (en) Pharmaceutical compounds
GB9609299D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990224

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19991025

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020301